SunPharma to Acquire 85.1% of Russia’s JSC Biosintez

SunPharma to Acquire 85.1% of Russia’s JSC Biosintez. Stake Sale In Jsc Biosintez For Approx $24 Mn. Deal To Also Include Taking Over Debt Of Approx $ 36 Mn. To Complete Acquisition By 2016 End In Cash

Sun Pharma Daily Charts Showing a Panic Bottom Made on US Presidential Election Results.

sunpharrma

0 comments… add one

Leave a Comment